Separation of full, empty, and partial adeno-associated virus capsids via anion-exchange chromatography with continuous recycling and accumulation

被引:3
作者
Lee, Yong Suk [1 ]
Lee, Jaeweon [2 ]
Fang, Kun [3 ]
Gee, Gretchen V. [3 ]
Rogers, Benjamin [3 ]
McNally, David [2 ,3 ]
Yoon, Seongkyu [2 ]
机构
[1] Univ Massachusetts, Dept Pharmaceut Sci, Lowell, MA USA
[2] Univ Massachusetts, Dept Chem Engn, Lowell, MA 01854 USA
[3] Univ Massachusetts, Chan Med Sch, MassBiol, Mattapan, MA 02126 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2024年 / 1242卷
关键词
Gene therapy; Adeno-associated virus; Continuous anion-exchange chromatography; N-Rich; Full/empty ratio; Partial capsid; GENE-THERAPY; AAV VECTORS; PURIFICATION; CHARGE; QUANTIFICATION; PARTICLES; DISEASES; DESIGN; TYPE-2; MODEL;
D O I
10.1016/j.jchromb.2024.124206
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The field of recombinant adeno-associated virus (rAAV) gene therapy has attracted increasing attention over decades. Within the ongoing challenges of rAAV manufacturing, the co-production of impurities, such as empty and partial capsids containing no or truncated transgenes, poses a significant challenge. Due to their potential impact on drug efficacy and clinical safety, it is imperative to conduct comprehensive monitoring and characterization of these impurities prior to the release of the final gene therapy product. Nevertheless, existing analytical techniques encounter notable limitations, encompassing low throughput, long turnaround times, high sample consumption, and/or complicated data analysis. Chromatography-based analytical methods are recognized for their current Good Manufacturing Practice (cGMP) alignment, high repeatability, reproducibility, low limit of detection, and rapid turnaround times. Despite these advantages, current anion exchange high pressure liquid chromatography (AEX-HPLC) methods struggle with baseline separation of partial capsids from full and empty capsids, resulting in inaccurate full-to-empty capsid ratio, as partial capsids are obscured within peaks corresponding to empty and full capsids. In this study, we present a unique analytical AEX method designed to characterize not only empty and full capsids but also partial capsids. This method utilizes continuous N-Rich chromatography with recycling between two identical AEX columns for the accumulation and isolation of partial capsids. The development process is comprehensively discussed, covering the preparation of reference materials representing full (rAAV-LacZ), partial (rAAV-GFP), and empty (rAAV-empty) capsids, N-rich method development, fraction analysis, determination of fluorescence response factors between capsid variants, and validation through comparison with other comparative techniques.
引用
收藏
页数:12
相关论文
共 59 条
  • [31] Comprehensive characterization and quantification of adeno associated vectors by size exclusion chromatography and multi angle light scattering
    McIntosh, Nicole L.
    Berguig, Geoffrey Y.
    Karim, Omair A.
    Cortesio, Christa L.
    De Angelis, Rolando
    Khan, Ayesha A.
    Gold, Daniel
    Maga, John A.
    Bhat, Vikas S.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] The Interplay between Adeno-Associated Virus and Its Helper Viruses
    Meier, Anita F.
    Fraefel, Cornel
    Seyffert, Michael
    [J]. VIRUSES-BASEL, 2020, 12 (06):
  • [33] CD8+ T-cell responses to adeno-associated virus capsid in humans
    Mingozzi, Federico
    Maus, Marcela V.
    Hui, Daniel J.
    Sabatino, Denise E.
    Murphy, Samuel L.
    Rasko, John E. J.
    Ragni, Margaret V.
    Manno, Catherine S.
    Sommer, Jurg
    Jiang, Haiyan
    Pierce, Glenn F.
    Ertl, Hildegund C. J.
    High, Katherine A.
    [J]. NATURE MEDICINE, 2007, 13 (04) : 419 - 422
  • [34] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Naso, Michael F.
    Tomkowicz, Brian
    Perry, William L., III
    Strohl, William R.
    [J]. BIODRUGS, 2017, 31 (04) : 317 - 334
  • [35] Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells
    Nguyen, Tam N. T.
    Sha, Sha
    Hong, Moo Sun
    Maloney, Andrew J.
    Barone, Paul W.
    Neufeld, Caleb
    Wolfrum, Jacqueline
    Springs, Stacy L.
    Sinskey, Anthony J.
    Braatz, Richard D.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 21 : 642 - 655
  • [36] Gene Therapy for Spinal Muscular Atrophy (SMA): A Review of Current Challenges and Safety Considerations for Onasemnogene Abeparvovec (Zolgensma)
    Ogbonmide, Tolu
    Rathore, Rajni
    Rangrej, Shahid B.
    Hutchinson, Stedrea
    Lewis, Marcia
    Ojilere, Stephenie
    Carvalho, Victoria
    Kelly, Irenaissia
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [37] Applications and developments of gene therapy drug delivery systems for genetic diseases
    Pan, Xiuhua
    Veroniaina, Hanitrarimalala
    Su, Nan
    Sha, Kang
    Jiang, Fenglin
    Wu, Zhenghong
    Qi, Xiaole
    [J]. ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 16 (06) : 687 - 703
  • [38] Patel A, 2019, METHODS MOL BIOL, V1950, P19, DOI 10.1007/978-1-4939-9139-6_2
  • [39] Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry
    Pierson, Elizabeth E.
    Keifer, David. Z.
    Asokan, Aravind
    Jarrold, Martin F.
    [J]. ANALYTICAL CHEMISTRY, 2016, 88 (13) : 6718 - 6725
  • [40] Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography
    Qu, Guang
    Bahr-Davidson, Jennifer
    Prado, Joseph
    Tai, Alex
    Cataniag, Floro
    McDonnell, Jennifer
    Zhou, Jingmin
    Hauck, Bernd
    Luna, Jac
    Sommer, Jurg M.
    Smith, Peter
    Zhou, Shangzhen
    Colosi, Peter
    High, Katherine A.
    Pierce, Glenn F.
    Wright, J. Fraser
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2007, 140 (1-2) : 183 - 192